Rates of delirium associated with calcium channel blockers compared to diuretics, renin-angiotensin system agents, and beta-blockers: an electronic health records network study

Rates of delirium associated with calcium channel blockers compared to diuretics, renin-angiotensin system agents, and beta-blockers: an electronic health records network study

<br><strong>Background: </strong>Antihypertensive drugs (AHTs), especially calcium channel blockers (CCBs), have been associated with differential rates of a number of neuropsychiatric outcomes. Delirium is commonly attributed to medication, including AHTs, but delirium incidence h...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Harrison, P, Luciano, S, Colbourne, L
Natura:	Journal article
Lingua:	English
Pubblicazione:	SAGE Publications 2020

Documenti analoghi

The renin-angiotensin system and its blockers
di: Igić Rajko, et al.
Pubblicazione: (2014-01-01)

Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic
di: Volpe M, et al.
Pubblicazione: (2012-06-01)

Calcium channel blockers, more than diuretics, enhance vascular protective effects of angiotensin receptor blockers in salt-loaded hypertensive rats.
di: Eiichiro Yamamoto, et al.
Pubblicazione: (2012-01-01)

Correction: Calcium Channel Blockers, More than Diuretics, Enhance Vascular Protective Effects of Angiotensin Receptor Blockers in Salt-Loaded Hypertensive Rats
Pubblicazione: (2013-01-01)

Renin-angiotensin system blockers and COVID-19
di: Emmanuelle Vidal-Petiot, et al.
Pubblicazione: (2021-06-01)

Effects of L-/N-Type Calcium Channel Blockers on Angiotensin II–Renin Feedback in Hypertensive Patients
di: Yutaka Kawabata, et al.
Pubblicazione: (2020-01-01)

A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention
di: Ji-Guang Wang
Pubblicazione: (2009-07-01)

The Combination of Beta Blockers and Renin-Angiotensin System Blockers Improves Survival in Incident Hemodialysis Patients: A Propensity-Matched Study
di: José Luño, et al.
Pubblicazione: (2017-07-01)

Addition of a renin-angiotensin-aldosterone system inhibitor to a calcium channel blocker ameliorates arterial stiffness
di: Kiuchi S, et al.
Pubblicazione: (2015-10-01)

Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders
di: Colbourne, C, et al.
Pubblicazione: (2022)

Beneficial Effects of Renin-Angiotensin System Blockers on Testicular Morphology
di: J. Alves-Pereira, et al.
Pubblicazione: (2017-06-01)

The use of renin-angiotensin system blockers in patients with COVID-19
di: Anton V. Rodionov
Pubblicazione: (2021-10-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
di: M. A. Maksimova, et al.
Pubblicazione: (2015-09-01)

Combined use of beta-blockers and non-dihydropyridine calcium channel blockers: possible or contraindicated?
di: S. S. Yakushin, et al.
Pubblicazione: (2024-02-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
di: M. A. Maksimova, et al.
Pubblicazione: (2015-09-01)

Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease
di: Rong-Shuang Huang, et al.
Pubblicazione: (2016-01-01)

Antihypertension drugs in prevention of cognition disorder and dementia: focus on calcium channel blockers and diuretics
di: O. D. Ostroumova, et al.
Pubblicazione: (2018-10-01)

Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke.
di: Rothwell, P, et al.
Pubblicazione: (2010)

Beta-blocker and calcium-channel blocker therapy in patients with cardiovascular pathologies during post-COVID period
di: A. G. Arutyunov, et al.
Pubblicazione: (2022-01-01)

Safety of beta-blocker and calcium channel blocker antihypertensive drugs in pregnancy: a Mendelian randomization study
di: Maddalena Ardissino, et al.
Pubblicazione: (2022-09-01)

Metabolomics Signature of Plasma Renin Activity and Linkage with Blood Pressure Response to Beta Blockers and Thiazide Diuretics in Hypertensive European American Patients
di: Mai Mehanna, et al.
Pubblicazione: (2021-09-01)

Selection of antihypertensive therapy in elderly patients, combination therapy: thiazide-like diuretics and calcium channel blockers
di: z. M. Galeyeva, et al.
Pubblicazione: (2018-12-01)

Impact of Renin‐Angiotensin System Blockers on Mortality in Veterans Undergoing Cardiac Surgery
di: Derrick T. Antoniak, et al.
Pubblicazione: (2021-05-01)

Renin-angiotensin system blockers regulate the metabolism of isolated fat cells in vitro
di: R de O. Caminhotto, et al.
Pubblicazione: (2016-07-01)

Renin-angiotensin-aldosterone system blockers as the main pathogenetic approach of drug nephroprotection
di: N.D. Filipets, et al.
Pubblicazione: (2019-02-01)

Interfacility Transfer for VA-ECMO in Beta Blocker and Calcium Channel Blocker Overdoses: A Report of Two Cases
di: Richard Fisher, et al.
Pubblicazione: (2025-01-01)

Comparison of Medical Treatments According to the Characteristics of Idiopathic Premature Ventricular Contractions: Beta-blockers or Calcium Channel Blockers?
di: Omer Faruk BAYCAN, et al.
Pubblicazione: (2023-03-01)

Early prophylaxis of cardiomyopathy with beta-blockers and angiotensin receptor blockers in patients with Duchenne muscular dystrophy
di: Heirim Lee, et al.
Pubblicazione: (2022-10-01)

Renin-Angiotensin-Aldosterone System Inhibitors, Statins, and Beta-Blockers in Diabetic Patients With Critical Limb Ischemia and Foot Lesions
di: Paolo Cimaglia MD, et al.
Pubblicazione: (2022-05-01)

Renal safety and survival among acutely ill hospitalized patients treated by blockers of the Renin-Angiotensin axis or loop diuretics: a single-center retrospective analysis
di: May Assaly, et al.
Pubblicazione: (2023-12-01)

Real-world efficacy of fimasartan vs. other angiotensin receptor blockers in combination with calcium channel blockers: a nationwide cohort study
di: Huijin Lee, et al.
Pubblicazione: (2024-10-01)

Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis
di: Haotian Ma, et al.
Pubblicazione: (2021-01-01)

Retrospective clinical study of renin-angiotensin system blockers in lung cancer patients with hypertension
di: Jie Wei, et al.
Pubblicazione: (2019-12-01)

Renin-angiotensin system blockers: therapy of choice in patients with arterial hypertension and heart failure
di: G. N. Gorokhovskaya, et al.
Pubblicazione: (2013-12-01)

Direct Renin Inhibitor is Better than Angiotensin II Receptor Blocker for Intrarenal Arterioles
di: Yohko Nagai, et al.
Pubblicazione: (2016-08-01)

Left ventricular hypertrophy and renin-angiotensin-aldosterone system: AT1-receptor blockers are in the focus
di: A V Barsukov, et al.
Pubblicazione: (2013-03-01)

Discovery and Development of Calcium Channel Blockers
di: Théophile Godfraind
Pubblicazione: (2017-05-01)

Renoprotective effect of calcium channel blockers
di: Dimković Nada, et al.
Pubblicazione: (2009-01-01)

Calcium Channel Blocker Overdose Simulation
di: Michael Maniaci, et al.
Pubblicazione: (2015-01-01)

Angiotensin II receptor blocker attenuates intrarenal renin-angiotensin-system and podocyte injury in rats with myocardial infarction.
di: Zhu-zhi Wen, et al.
Pubblicazione: (2013-01-01)